Customer Service: 952-500-7200 Technical Support & Order Status

Borreliella burgdorferi NapA

The Gram-negative bacterium Borreliella burgdorferi is one of the pathogens of the Borreliella burgdorferi sensu lato complex causing Lyme disease. B. burgdorferi neutrophil activating protein A (NapA) interferes with the host's immune system by inducing a humoral immune response. DIARECT™ antigens are for further manufacturing or research use only.

Origin
Recombinant. Expressed in E. coli bacterial cells.
Biochemical Test
SDS-PAGE (purity> 80%); Western blot with anti-His-tag antibody.
Calculated Molecular Weight
22 kDa
Calculated Isoelectric Point
pH 5.81

A413


Filter
Option Quantity Unit Purchase
Borrelia burgdorferi NapA
A41300
 50 µg
$195.00/EA
Please contact us for availability In Stock
Borrelia burgdorferi NapA
A41301
 1.0 mg
$1,940.00/EA
Please contact us for availability Please contact us for availability
With Selected Items:

Contact Us

Our team has the expertise and commitment to provide best-in-class solutions to meet your IVD needs.

Technical Support
& Order Status

Customer Service
952-500-7200

Surmodics IVD, Inc.
9924 West 74th Street
Eden Prairie, MN 55344 USA
Direct: 952-500-7200
Fax: 952-500-7201

Surmodics: Medical Device Coatings, Products, and IVD Technologies for the Healthcare Industry.

Privacy Policy | Terms of Use

Surmodics Standard Terms and Conditions
© 2026 Surmodics, Inc. All Rights Reserved.

SURMODICS, STABILBLOCK, STABILBLOT, STABILCOAT, STABILGUARD, STABILMAX, MATRIXGUARD, TRIDIA, BIOFX, STABILZYME, STABILZYME SELECT, and the SURMODICS logo are trademarks of Surmodics, Inc. and/or its affiliates. CODELINK is the registered trademark of GE Healthcare UK, Ltd. and/or its affiliates. BBI SOLUTIONS, DIARECT, and BBI SOLUTIONS and DIARECT logos are trademarks of the BBI Group and/or its affiliates.